1.
Flores TG, Antunes Gonçalves CF, Barbisan F, Manica da Cruz IB, Agostini Lampert M, Cardoso de Afonso Bonotto N, Niero Volpato I. Epidemiological survey on the benefit of neuraminidase inhibitors on severe acute respiratory syndrome due to COVID-19. Rev Epidemiol Control Infect [Internet]. 2023Jun.16 [cited 2024May18];13(1). Available from: https://online.unisc.br/seer/index.php/epidemiologia/article/view/17973